Are TP53 Arg72Pro and MDM2 T309G polymorphisms associated with bladder cancer risk? A meta-analysis. Abderrahmane RK, Touala-Chaila Z, Benseddik K, Hassani N, et al. Afr Health Sci 2024;24:118-127.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Abderrahmane RK, Touala-Chaila Z, Benseddik K, Hassani N, et al. Are TP53 Arg72Pro and MDM2 T309G polymorphisms associated with bladder cancer risk? A meta-analysis. Afr Health Sci 2024;24:118-127.
PMID: 40777979